Company intelligence / Profile preview

Medical Intelligence Group

Wirral, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

MIG is validating proprietary AI and 3D scanning systems for early detection and monitoring of diabetic foot ulcers in partnership with NHS, aiming to reduce amputations and healthcare burden in diabetes care[1][2].

Therapeutic areas: Endocrinology
Modalities: DeviceArtificial intelligence software
Industry: Medical Imaging

Partnerships

NHS (participating in pilot trial)[1][2]Innovate UKInnovate UK EDGEEnterprise Europe Network (grant/support partners)[1][2][3]

Beyond the preview

Go deeper on Medical Intelligence Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medical Intelligence Group.

Explore the full profile